These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9437909)

  • 21. Increased norfloxacin skin permeability for fatty alcohol propylene glycol (FAPG) ointment by optimized process of preparation: behavior of stearic acid in stratum corneum lipids.
    Lin HH; Hsu LR; Wu PC; Tsai YH
    Biol Pharm Bull; 1995 Nov; 18(11):1560-5. PubMed ID: 8593480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-beta-cyclodextrin and penetration enhancers.
    Uekama K; Adachi H; Irie T; Yano T; Saita M; Noda K
    J Pharm Pharmacol; 1992 Feb; 44(2):119-21. PubMed ID: 1352811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients.
    Rosenkranz B
    Horm Metab Res; 1996 Sep; 28(9):434-9. PubMed ID: 8911979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microcapsules and transdermal patch: a comparative approach for improved delivery of antidiabetic drug.
    Mishra MK; Ray D; Barik BB
    AAPS PharmSciTech; 2009; 10(3):928-34. PubMed ID: 19629706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfonylureas stimulate renin secretion from the perfused kidney of the rat.
    Ochi H; Ikeda T
    Nephron; 1999 Jan; 81(1):67-71. PubMed ID: 9884422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyoxyethylene fatty acid esters as potential promotors of transdermal absorption for morphine hydrochloride and sulphate.
    Samczewska G; Piechota-Urbańska M; Kołodziejska J
    Polim Med; 2006; 36(2):17-32. PubMed ID: 17022153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on absorption and accumulation of mercury in rats by repeated administration of Yuhong ointment].
    Qiu H; Sun XM; Huang W; Hu XJ; Wang Q; Mou JZ; Wang LX
    Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(6):884-8. PubMed ID: 23717973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gel ointment of verapamil for percutaneous absorption.
    Sekine T; Machida Y; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):245-52. PubMed ID: 3509338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats.
    Ladrière L; Malaisse-Lagae F; Fuhlendorff J; Malaisse WJ
    Eur J Pharmacol; 1997 Sep; 335(2-3):227-34. PubMed ID: 9369378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Betamethasone valerate ointment compared with fluocinonide FAPG.
    Munro DD; Robinson TW; du Vivier AW; France DM; Clayton R; Sparkes CG
    Arch Dermatol; 1977 May; 113(5):599-601. PubMed ID: 856049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External control of drug release and penetration: enhancement of the transdermal absorption of indomethacin by ultrasound irradiation.
    Miyazaki S; Mizuoka H; Oda M; Takada M
    J Pharm Pharmacol; 1991 Feb; 43(2):115-6. PubMed ID: 1672894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide.
    Ikenoue T; Okazaki K; Fujitani S; Tsuchiya Y; Akiyoshi M; Maki T; Kondo N
    Biol Pharm Bull; 1997 Apr; 20(4):354-9. PubMed ID: 9145209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glibenclamide Nanocrystals in a Biodegradable Chitosan Patch for Transdermal Delivery: Engineering, Formulation, and Evaluation.
    Ali HSM; Hanafy AF
    J Pharm Sci; 2017 Jan; 106(1):402-410. PubMed ID: 27866687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological evaluation of membrane-moderated transdermal system of glipizide.
    Mutalik S; Udupa N
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):17-26. PubMed ID: 16445694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.
    Kikuchi M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S151-5. PubMed ID: 8894500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro skin penetration of griseofulvin in rat and human skin from an ointment dosage form.
    Ritschel WA; Hussain AS
    Arzneimittelforschung; 1988 Nov; 38(11):1630-2. PubMed ID: 3214448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical therapies for rheumatoid arthritis by gel ointments containing indomethacin nanoparticles in adjuvant-induced arthritis rat.
    Nagai N; Yoshioka C; Ito Y
    J Oleo Sci; 2015; 64(3):337-46. PubMed ID: 25757439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Penetration kinetics of fluocortolone from a new base for ointment and creme (author's transl)].
    Flasch H; Hofferber E
    Arzneimittelforschung; 1980; 30(4):652-6. PubMed ID: 7190408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.